ABSTRACT
INTRODUCTION
Obesity primarily is considered as an environmental and behavioral problem and now viewed as a complex disorder and a major health risk factor related to increased cardiovascular disease (CVD), stroke, diabetes mellitus, hypertension, cancer and early death (1) . Framingham Heart Study showed that obese individuals had an increase in the risk of heart failure compared to non obese individuals (2) . Those with abdominal obesity are at greater risk for diabetes, CVD and all-cause mortality (3) . There are cross relations between the CVD risk and increased waist circumference and there is now concept that the accumulated visceral fat depot acts as a large endocrine gland that becomes inflamed, secreting adipokines that may produce an insulin resistance and proinflammatory state that increases cardiovascular disease risk (4) . Body weight control is the cornerstone of both primary and secondary prevention of CVD (5) . Adipokines such as leptin, adiponectin, resistin and retinol binding protein 4 were reported to have a role in obesity and other cardiovascular disease (6) . RBP4 is 21kDa secreted protein, member of lipocalin family (7) and is one of fatty acid binding proteins adipokine which has been correlated significantly to both obesity and cardiovascular disease (8) . RBP4 dysregulation may be associated with altered hepatic (9) , and renal function (10) , lipid metabolism and inflammation (11) . Relationships between RBP4 and other traditional and non-traditional risk factors for CVD, such as inflammatory factors and oxidative stress have been reported in larger populations (12) . Leptin is a satiety element produced from adipocytes (13) and has direct protective actions against obesity and CVD (14) . Adiponectin is an adipose tissue specific hormone that has insulin sensitizing properties, antiinflammatory properties and is protective against obesity related disorders (13) . Numerous other nontraditional risk factors are of particular importance in the context of CVD such as thrombotic and inflammatory biomarkers i.e. plasminogen activator inhibitor-1 (PAI-1), . Oxidative stress appears to play a major role in the development of CVD (15) . Oxidative stress which is an imbalance between tissue oxidants (free radicals or reactive oxygen species) and antioxidants has major role in the development of major obesity-related complications such as CVD and diabetes The aim of the present study is to show the relation between the levels of serum RBP4 and plasma Total thiols (TT) in generalized obesity (GO) and abdominal obesity (AO) and to study other risk factors such as levels of HbA 1c %), C-reactive protein (CRP) and lipid profile in both AO & GO. 
MATERIAL & METHOD

Laboratory investigation:
Venous blood samples were collected from each subject after fasting for 12 hours, part of the sample was placed in plane tube (no anticoagulant), centrifuged at 3,000 rpm (1,000 xg) for 20 minutes at 4°C and the serum was separated. The other part of blood sample was placed in tube having EDTA, mixed by inversion and part was used for estimation of blood HbA 1c and the remaining part of the EDTA sample was centrifuged at 3,000 rpm (1,000xg) for 20 minutes at 4°C and the plasma was separated. All aliquots were stored at -70°C up to patch analysis of biomarkers. Serum RBP-4 levels were measured by enzymelinked immunosorbent assays (ELISA) using commercial kits (e.g. R&D Systems, Abingdon, Oxfordshire, United Kingdom). Plasma levels of TT were measured by colorimetric methods (20) . The inter-and intra-assay coefficients of variation for all assays were <5% and <10% respectively. Hitachi 911 automated analyzer at Assiut University Hospital Laboratory was used for estimation of fasting blood glucose (FBG) (8-hour fasting), twohour postprandial blood glucose (2-h PPBS) , HbA 1C and serum fasting lipid profile (12-hour fasting) which included LDL-C, HDL-C, total cholesterol and triglyceride. Serum creatinine level was also measured.
Statistical Analysis:
Following application of the Shapiro-Wilkes test to determine a normal distribution, non-categorical data distributed normally are expressed as mean ±standard deviation and data distributed non-normally are expressed as median (inter quartile range). Categorical data are analyzed by the Chi-squared test (χ 2 ). Continuously variable data are analyzed by ANOVA or the Kruskal-Wallis test. Turkey's post-hoc test was used to determine differences between groups. Correlations were assayed by Spearman's rank method. A probability of less than 0.05 was considered as statistically significant. Analyses were done using SPSS version 16.
RESULTS
Patients with AO showed significantly higher circulating RBP-4, FBG, 2 hours postprandial blood glucose, blood HbA 1c and CRP compared to those with GO (p<0.05 for each) and to controls, p<0.05 for each (Tables 2 &4; Figures 2). Total thiol (TT) levels were significantly lower in obese subjects with AO compared to those with GO (p<0.05 for each) and to controls, p<0.05 for each (Tables 2 &4; Figures 1) . However, the difference in the levels of TT in obese subjects with GO and non-obese control subjects was insignificant.
The levels of total cholesterol, triglyceride and LDL-C showed no significant difference between obese with AO and those with GO, the HDL-c levels were slightly lower in obese with AO than those GO, but the difference was insignificant.
Positive significant correlations (Spearman's rho) were evident between RBP-4 and levels of HbA 1c % in AO and GO (r=0.371, 0.567 respective, P<0.05 for each). No significant correlation between HbA1c and total thiol in AO and GO (r=0.147, 0.143 respective, P>0.05 for each). No significant correlations between RBP-4 and CRP in AO and GO groups were obtained (r=0.075, 0.158 respective, P>0.05 for each). There was significant difference between AO and GO for DM, HTN, physical inactivity, weight, height, BMI, WC, hip circumference and waist/hip ratio, P<0.05 for each (Table 5) . . AO group has significantly lower serum levels of TT compared to GO (p<0.05). AO has significantly higher levels of HbA1c compared to GO (p<0.05). *Significant Statistical difference between (AO) & (GO). AO had significantly lower total thiols levels compared to GO (p< 0.05). 
DISCUSSION
The current study investigated the serum levels of RBP4 in obese people with cardiovascular disease. The study demonstrated that obese individuals with AO have elevated concentrations of RBP4 than those with GO and also demonstrated that blood levels of HbA 1c were significantly elevated in individuals with higher serum levels of RBP4 compared to individuals with low serum levels of RBP4. This result coincides with what was reported by Lee et al.
(12) that RBP4 concentrations is linked with distribution of body fat rather than body weight per se since it ' s more highly correlated with waist/hip ratio or visceral fat than with BMI. In addition Cho et al. (21) reported that plasma concentrations of RBP4 were significantly higher in subjects with impaired glucose tolerance (IGT) or Type 2 DM compared to subjects with normal glucose tolerance. Yang et al. (7) reported that circulating RBP4 increased in obese subjects with type 2 DM. Koch et al.
(22) demonstrated that plasma or serum RBP4 concentrations correlated with the severity of insulin resistance in non diabetic participants with family history of type 2DM. So, RBP4 is considered as a convenient marker not only for T2DM but also as an indicator for adiposity.
In the present study, we used BMI, WC and W/H ratio circumference as measures for AO & GO to investigate the relationship between adiposity and cardiovascular risk factors (DM, HTN, physical inactivity, smoking, coronary artery disease, chronic kidney disease, peripheral arterial disease and family history of premature CAD) in both men and women. This coincided with what stated by Escribano García et al.
(24) that the BMI and WC are the most widely used parameters for determining obesity because they are easily obtained.
Our results showed that HTN and DM are more prevalent among individuals with abdominal obesity highlighting the relationship between abdominal obesity and cardiovascular risk factors and such fact stands in males and females. Escribano García et al.
(23) verified strong correlations between generalized obesity and either high blood pressure and diabetes mellitus.
There were strong associations between coronary artery disease (CAD) and obesity irrespective to its type and sex difference. Large casecontrol study demonstrated that WHR was more strongly associated with CAD than with BMI in both men and women (24) . Rocha et al. (25) reported that obesity represents a major risk factor for atherosclerosis, in which systemic obesity-related inflammation is believed to be the main culprit.
There were inverse relations between physical activity and both types of obesity either abdominal or generalized in the present study, since physical inactivity was higher among abdominally obese than generalized obese individuals. Since the lipogram stands to be the molecular evidence for our study, we established that all lipid parameters were abnormally higher (but insignificant) in abdominally obese individuals compared to generalized obese individuals except for HDL-C which was abnormally lower in AO than in GO. Coinciding with these results , Escribano García et al. (24) reported that smaller differences in hypercholesterolemia for the different levels of obesity based on BMI and abdominal obesity were found. There were consistent changes in HDL-C and triglycerides with obesity, since obesity seems to be associated with lower HDL-C and increased triglycerides in people of all ethnic groups but less consistent change on LDL-C concentrations has been found (30) . Our study showed that CRP was found to be higher in abdominal obesity group than generalized obesity group in women and men. Bochud et al., (31) reported that CRP gene expression was positively increased with high BMI, WC and fat mass in women, whereas no such evidence was found in men. 
